Reach4Sky is Bi-Coastal in 2019 : Oceanside (September 2) & Boston (September 21)

Mrs.

Cure SMA Breaking News

no more sma angels

Two significant FDA approved treatments are changing the course of SMA.

MAY 2019 - FDA APPROVES ZOLGENSMA

image13

 AveXis Receives FDA Approval of Zolgensma, a Gene Therapy, for Spinal Muscular Atrophy for Patients Under Two Years of Age.

Find out more

DECEMBER 2016 - FDA APPROVES SPINRAZA

image14

  On December 23, 2016, the FDA approved Spinraza (nusinersen) to treat Spinal Muscular Atrophy, making it the first-ever FDA-approved therapy for SMA.  

Find out more